Pak2 siRNA/shRNA/RNAi
To Order Contact us: lieven@wlsolutions.be
pROKII- RNAI Plasmid |
||
PVT3202 | 2 ug | EUR 319.2 |
T7 RNAi Transcription Kit |
||
TR102-01 | 25 rxn | EUR 307.2 |
T7 RNAi Transcription Kit |
||
TR102-02 | 50 rxn | EUR 484.8 |
GeneGlide? RNAi Delivery Control |
||
M1082-10 | each | EUR 284.4 |
GeneGlide? RNAi Delivery Control |
||
M1082-100 | each | EUR 1002 |
GeneGlide? RNAi Delivery Control |
||
M1082-50 | each | EUR 594 |
PAK2 |
||
40073 | 10 µg | EUR 495 |
Description: Human PAK2 (GenBank Accession No. NM_002577), a.a. 227-524, MW=33.5 kDa, expressed in E. coli. |
Pak2/ Rat Pak2 ELISA Kit |
||
ELI-22010r | 96 Tests | EUR 1063.2 |
PAK2 antibody |
||
70R-11828 | 100 ug | EUR 470.4 |
Description: Rabbit polyclonal PAK2 antibody |
PAK2 antibody |
||
70R-50168 | 100 ul | EUR 344.4 |
Description: Purified Polyclonal PAK2 antibody |
PAK2 antibody |
||
70R-19097 | 50 ul | EUR 522 |
Description: Rabbit polyclonal PAK2 antibody |
PAK2 antibody |
||
70R-32706 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody |
PAK2 antibody |
||
70R-32708 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody |
PAK2 antibody |
||
70R-32710 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody |
PAK2 antibody |
||
70R-31506 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody |
PAK2 Antibody |
||
3885-002mg | 0.02 mg | EUR 206.18 |
Description: PAK2 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6, and are not activated by Cdc42/Rac binding. Of the six PAK proteins, only PAK2 is ubiquitously expressed and cleaved by caspase-3. This cleavage removes the amino-terminal regulatory domain and generates a constitutively active kinase fragment. Recent experiments have shown that following cleavage, the active fragment is myristoylated and directed to the plasma membrane and membrane ruffles where it promotes cell death via increased signaling through the c-Jun N-terminal kinase pathway, but without compromising mitochondrial integrity. |
PAK2 Antibody |
||
3885-01mg | 0.1 mg | EUR 523.7 |
Description: PAK2 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6, and are not activated by Cdc42/Rac binding. Of the six PAK proteins, only PAK2 is ubiquitously expressed and cleaved by caspase-3. This cleavage removes the amino-terminal regulatory domain and generates a constitutively active kinase fragment. Recent experiments have shown that following cleavage, the active fragment is myristoylated and directed to the plasma membrane and membrane ruffles where it promotes cell death via increased signaling through the c-Jun N-terminal kinase pathway, but without compromising mitochondrial integrity. |
PAK2 Peptide |
||
3885P | 0.05 mg | EUR 197.7 |
Description: (CT) PAK2 peptide |
PAK2 Antibody |
||
3887-002mg | 0.02 mg | EUR 206.18 |
Description: PAK2 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6, and are not activated by Cdc42/Rac binding. Of the six PAK proteins, only PAK2 is ubiquitously expressed and cleaved by caspase-3. This cleavage removes the amino-terminal regulatory domain and generates a constitutively active kinase fragment. Recent experiments have shown that following cleavage, the active fragment is myristoylated and directed to the plasma membrane and membrane ruffles where it promotes cell death via increased signaling through the c-Jun N-terminal kinase pathway, but without compromising mitochondrial integrity. |
PAK2 Antibody |
||
3887-01mg | 0.1 mg | EUR 523.7 |
Description: PAK2 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6, and are not activated by Cdc42/Rac binding. Of the six PAK proteins, only PAK2 is ubiquitously expressed and cleaved by caspase-3. This cleavage removes the amino-terminal regulatory domain and generates a constitutively active kinase fragment. Recent experiments have shown that following cleavage, the active fragment is myristoylated and directed to the plasma membrane and membrane ruffles where it promotes cell death via increased signaling through the c-Jun N-terminal kinase pathway, but without compromising mitochondrial integrity. |
PAK2 Peptide |
||
3887P | 0.05 mg | EUR 197.7 |
Description: (NT) PAK2 peptide |
PAK2 Antibody |
||
49859-100ul | 100ul | EUR 399.6 |
PAK2 Antibody |
||
49859-50ul | 50ul | EUR 286.8 |
PAK2 Antibody |
||
35863-100ul | 100ul | EUR 302.4 |
PAK2 antibody |
||
20R-1575 | 100 ug | EUR 716.4 |
Description: Rabbit polyclonal PAK2 antibody |
PAK2 antibody |
||
10R-1807 | 100 ul | EUR 548.4 |
Description: Mouse monoclonal PAK2 antibody |
PAK2 Antibody |
||
24441-100ul | 100ul | EUR 468 |
PAK2 Antibody |
||
24442-100ul | 100ul | EUR 468 |
PAK2 Antibody |
||
BF0195 | 200ul | EUR 540 |
PAK2 Antibody |
||
1-CSB-PA552213 |
|
|
Description: A polyclonal antibody against PAK2. Recognizes PAK2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:50-1:200 |
PAK2 Antibody |
||
1-CSB-PA622641DSR1HU |
|
|
Description: A polyclonal antibody against PAK2. Recognizes PAK2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
PAK2 Antibody |
||
1-CSB-PA922459 |
|
|
Description: A polyclonal antibody against PAK2. Recognizes PAK2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200 |
PAK2 Antibody |
||
AF2681 | 100ul | EUR 420 |
PAK2 Antibody |
||
1-CSB-PA017406GA01HU |
|
|
Description: A polyclonal antibody against PAK2. Recognizes PAK2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
PAK2 Antibody |
||
1-CSB-PA020229 |
|
|
Description: A polyclonal antibody against PAK2. Recognizes PAK2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000 |
PAK2 Antibody |
||
1-CSB-PA020230 |
|
|
Description: A polyclonal antibody against PAK2. Recognizes PAK2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
PAK2 Antibody |
||
1-CSB-PA010537 |
|
|
Description: A polyclonal antibody against PAK2. Recognizes PAK2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
anti-PAK2 |
||
YF-PA13608 | 50 ul | EUR 435.6 |
Description: Mouse polyclonal to PAK2 |
anti-PAK2 |
||
YF-PA13609 | 100 ug | EUR 483.6 |
Description: Rabbit polyclonal to PAK2 |
SYNERGY PAK2 |
||
SYPK0SIX2 | EACH | EUR 419.52 |
PAK2 Antibody |
||
F50891-0.08ML | 0.08 ml | EUR 165 |
PAK2 Antibody |
||
F50891-0.4ML | 0.4 ml | EUR 379 |
PAK2 Antibody |
||
3443-100 | each | EUR 379.2 |
PAK2 Antibody |
||
3443-30T | each | EUR 175.2 |
shRNA-H1 (Neg)-(blasticidin) lentivirus |
||
H1(shRNA-Ctr)-Bsd | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Blasticidin marker under Rsv promoter. |
shRNA-H1 (Neg)-(Puromycin) lentivirus |
||
H1(shRNA-Ctr)-Puro | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
shRNA-U6 (Neg)-(blasticidin) lentivirus |
||
U6(shRNA-Ctr)-Bsd | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Blasticidin marker under Rsv promoter. |
shRNA-U6 (Neg)-(Puromycin) lentivirus |
||
U6(shRNA-Ctr)-Puro | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
pAd/BLOCK-iT-DEST RNAi Gateway Vector |
||
PVT12297 | 2 ug | EUR 1342.8 |
PAK2 antibody (Ser192) |
||
70R-32705 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody (Ser192) |
PAK2 antibody (Ser141) |
||
70R-32707 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody (Ser141) |
PAK2 antibody (Ser197) |
||
70R-32709 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody (Ser197) |
PAK2 antibody (Ser20) |
||
70R-31505 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal PAK2 antibody (Ser20) |
PAK2 Blocking Peptide |
||
33R-10761 | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PAK2 antibody, catalog no. 70R-11828 |
PAK2 Blocking Peptide |
||
33R-10490 | 50 ug | EUR 418.8 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PAK2 antibody, catalog no. 20R-1575 |
PAK2 Rabbit mAb |
||
A4553-100ul | 100 ul | EUR 492 |
PAK2 Rabbit mAb |
||
A4553-200ul | 200 ul | EUR 685.2 |
PAK2 Rabbit mAb |
||
A4553-20ul | 20 ul | EUR 265.2 |
PAK2 Rabbit mAb |
||
A4553-50ul | 50 ul | EUR 344.4 |
PAK2 Blocking Peptide |
||
20-abx061704 |
|
|
PAK2 (pS20) Antibody |
||
20-abx009830 |
|
|
PAK2 Rabbit pAb |
||
A7333-100ul | 100 ul | EUR 369.6 |
PAK2 Rabbit pAb |
||
A7333-200ul | 200 ul | EUR 550.8 |
PAK2 Rabbit pAb |
||
A7333-20ul | 20 ul | EUR 219.6 |
PAK2 Rabbit pAb |
||
A7333-50ul | 50 ul | EUR 267.6 |
PAK2 (pS197) Antibody |
||
abx333096-100ul | 100 ul | EUR 560.4 |
Polyclonal PAK2 Antibody |
||
APR00106G | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PAK2 Antibody |
||
APR06418G | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PAK2 Antibody |
||
APR06419G | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK2 . This antibody is tested and proven to work in the following applications: |
PAK2 Blocking Peptide |
||
BF0195-BP | 1mg | EUR 234 |
PAK2 Conjugated Antibody |
||
C35863 | 100ul | EUR 476.4 |
PAK2 Conjugated Antibody |
||
C49859 | 100ul | EUR 476.4 |
PAK2 cloning plasmid |
||
CSB-CL622641HU-10ug | 10ug | EUR 661.2 |
Description: A cloning plasmid for the PAK2 gene. |
PAK1 /PAK2 Antibody |
||
AF2680 | 100ul | EUR 420 |
Anti-PAK2 antibody |
||
PAab06122 | 100 ug | EUR 494.4 |
anti-PAK2 (3B5) |
||
LF-MA30296 | 100 ul | EUR 656.4 |
Description: Mouse Monoclonal to PAK2 |
anti- PAK2 antibody |
||
FNab06122 | 100µg | EUR 702 |
Description: Antibody raised against PAK2 |
Anti-PAK2 antibody |
||
STJ11100066 | 100 µl | EUR 495.6 |
Description: The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. |
Anti-PAK2 antibody |
||
STJ29472 | 100 µl | EUR 332.4 |
Description: The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell. |
Anti-PAK2 (1E1) |
||
YF-MA14588 | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to PAK2 |
PAK2 Polyclonal Antibody |
||
A73392-050 | 50 ul | EUR 377.3 |
PAK2 Polyclonal Antibody |
||
A73392-100 | 100 ul | EUR 577.5 |
PAK2 Polyclonal Antibody |
||
A73392 |
|
|
PAK2 Blocking Peptide |
||
3443BP-50 | each | EUR 183.6 |
shRNA-H1 (Neg)-( GFP-Bsd) lentivirus |
||
H1(shRNA-Ctr)-GB | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a GFP-Blasticidin fusion marker under Rsv promoter. |
shRNA-H1 (Neg)-( GFP-Puro) lentivirus |
||
H1(shRNA-Ctr)-GP | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a GFP-Puromycin fusion marker under Rsv promoter. |
shRNA-H1 (Neg)-( RFP-Bsd) lentivirus |
||
H1(shRNA-Ctr)-RB | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a RFP-Blasticidin fusion marker under Rsv promoter. |
shRNA-H1(Neg)-( RFP-Puro) lentivirus |
||
H1(shRNA-Ctr)-RP | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a RFP-puromycin fusion marker under Rsv promoter. |
shRNA-U6 (Neg)-( GFP-Bsd) lentivirus |
||
U6(shRNA-Ctr)-GB | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a GFP-Blasticidin fusion marker under Rsv promoter. |
shRNA-U6 (Neg)-( GFP-Puro) lentivirus |
||
U6(shRNA-Ctr)-GP | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a GFP-Puromycin fusion marker under Rsv promoter. |
shRNA-U6 (Neg)-( RFP-Bsd) lentivirus |
||
U6(shRNA-Ctr)-RB | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a RFP-Blasticidin fusion marker under Rsv promoter. |
shRNA-U6 (Neg)-( RFP-Puro) lentivirus |
||
U6(shRNA-Ctr)-RP | 1 x107 IFU/ml x 200ul | EUR 418.8 |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a RFP-puromycin fusion marker under Rsv promoter. |
PAK2 (Phospho-Ser815) Antibody |
||
13251-100ul | 100ul | EUR 302.4 |
PAK2 (Phospho-Ser815) Antibody |
||
13251-50ul | 50ul | EUR 224.4 |
PAK2 (Phospho-Ser197) Antibody |
||
11749-100ul | 100ul | EUR 302.4 |
PAK2 (Phospho-Ser197) Antibody |
||
11749-50ul | 50ul | EUR 224.4 |
PAK2 (Phospho-Ser141) Antibody |
||
12117-100ul | 100ul | EUR 302.4 |
PAK2 (Phospho-Ser141) Antibody |
||
12117-50ul | 50ul | EUR 224.4 |
PAK2 (Ab-192) Antibody |
||
33242-100ul | 100ul | EUR 302.4 |
PAK2 (Ab-192) Antibody |
||
33242-50ul | 50ul | EUR 224.4 |
PAK2 (Ab-141) Antibody |
||
33243-100ul | 100ul | EUR 302.4 |
PAK2 (Ab-141) Antibody |
||
33243-50ul | 50ul | EUR 224.4 |
PAK2 (Ab-197) Antibody |
||
33244-100ul | 100ul | EUR 302.4 |
PAK2 (Ab-197) Antibody |
||
33244-50ul | 50ul | EUR 224.4 |
PAK1/PAK2/PAK3 antibody |
||
20R-2015 | 50 ug | EUR 337.2 |
Description: Rabbit polyclonal PAK1/PAK2/PAK3 antibody |
PAK1/PAK2/PAK3 antibody |
||
20R-2337 | 50 ug | EUR 337.2 |
Description: Rabbit polyclonal PAK1/PAK2/PAK3 antibody |
PAK2 recombinant monoclonal antibody |
||
A5588 | 100ul X 3 | EUR 714 |
Description: A recombinant monoclonal antibody from rabbit against human PAK2 for WB, IHC, IF,ELISA |
PAK2 (pS20) Blocking Peptide |
||
20-abx063043 |
|
|
Phospho- PAK2 (Ser20) Antibody |
||
ABF3693 | 100 ug | EUR 525.6 |
PAK2 (Phospho- Ser141) Antibody |
||
ABF9245 | 100 ug | EUR 525.6 |
PAK1 / PAK2 / PAK3 Antibody |
||
20-abx326657 |
|
|
PAK1 / PAK2 / PAK3 Antibody |
||
20-abx328532 |
|
|
PAK2 (Ab-197) Antibody |
||
CSB-PA827528-100ul | 100ul | EUR 379.2 |
Description: A polyclonal antibody against PAK2 (Ab-197). Recognizes PAK2 (Ab-197) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |